wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q55649893-2EE17A66-A5D5-4E55-B64D-87E4A14AC4E7
Q55649893-2EE17A66-A5D5-4E55-B64D-87E4A14AC4E7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55649893-2EE17A66-A5D5-4E55-B64D-87E4A14AC4E7
Susceptibility to serious skin and subcutaneous tissue disorders and skin tissue distribution of sodium-dependent glucose co-transporter type 2 (SGLT2) inhibitors.
P2860
Q55649893-2EE17A66-A5D5-4E55-B64D-87E4A14AC4E7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55649893-2EE17A66-A5D5-4E55-B64D-87E4A14AC4E7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f82188a4b0dc973274d5d346af6624c37692fff9
P2860
Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study).